Framing the risk of an OTC medication side effect (original) (raw)
Positively Framed Risk Information in Patient Information Leaflets Reduces Side Effect Reporting: A Double-Blind Randomized Controlled Trial
Rebecca K. Webster
Annals of behavioral medicine : a publication of the Society of Behavioral Medicine, 2018
View PDFchevron_right
Changes in Side Effect Risk Communication in Patient Information Leaflets over the Past Decade: Results of a Survey
Peter Knapp
Drug safety, 2015
View PDFchevron_right
Is 15 per cent very common? Informing people about the risks of medication side effects
Peter Knapp
International Journal of Pharmacy Practice, 2002
View PDFchevron_right
Communicating the Risk of Side Effects to Patients
Dr Brian McMillan
Drug Safety, 2009
View PDFchevron_right
Expressing medicine side effects: Assessing the effectiveness of absolute risk, relative risk, and number needed to harm, and the provision of baseline risk information
Peter Knapp
Patient Education and Counseling, 2006
View PDFchevron_right
Discussing side effects of over-the-counter medicines: impact of adding percentage data
Dale Quest
The International journal of pharmacy practice, 2010
View PDFchevron_right
How does the side-effect information in patient information leaflets influence peoples' side-effect expectations? A cross-sectional national survey of 18- to 65-year-olds in England
Rebecca K. Webster
Health expectations : an international journal of public participation in health care and health policy, 2017
View PDFchevron_right
Consumers Prefer Drug Side Effect Information to be Rich in Detail and Easily Accessible
Salman Mirza
View PDFchevron_right
Exploring consumer opinions on the presentation of side-effects information in Australian Consumer Medicine Information leaflets
Susan Blalock
Health Expectations, 2014
View PDFchevron_right
Patients’ Use of Information about Medicine Side Effects in Relation to Experiences of Suspected Adverse Drug Reactions: A Cross-Sectional Survey in Medical In-Patients
Janet Krska
Drug Safety, 2013
View PDFchevron_right
Desire for information about drugs: relationships with patients' characteristics and adverse effects
Ian Bates
Pharmacy world & science : PWS, 2002
View PDFchevron_right
What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs
Andrew Moore
Arthritis Research & Therapy, 2008
View PDFchevron_right
Adequacy of Patient Information on Adverse Effects
Peter Knapp
Drug Safety, 2008
View PDFchevron_right
Do pharmacists’ reports of adverse drug reactions reflect patients’ concerns?
Kees van Grootheest, Lolkje de Jong-van Den Berg
Pharmacy World & Science, 2000
View PDFchevron_right
Evaluating a combined (frequency and percentage) risk expression to communicate information on medicine side effects to patients
Dr Brian McMillan
International Journal of Pharmacy Practice, 2012
View PDFchevron_right
What can we learn from the public's understanding of drug information and safety? A population survey
Bendaoud Saad
International Journal of Pharmacy Practice, 2018
View PDFchevron_right
Enhancing Patient Understanding of Medication Risks and Benefits
Susan Blalock
Arthritis Care & Research, 2020
View PDFchevron_right
Short- and Long-Term Effects of Auxiliary Labels on Patient Knowledge of Precautionary Drug Information
Brock Guernsey
Drug Intelligence & Clinical Pharmacy, 1988
View PDFchevron_right
The effect of counseling on willingness to use a hypothetical medication and perceptions of medication safety
Peter Knapp
Research in social & administrative pharmacy : RSAP, 2017
View PDFchevron_right
When direct health-care professional communications have an impact on inappropriate and unsafe use of medicines
P. Mol, Jaap Wieringa
Clinical pharmacology and therapeutics, 2013
View PDFchevron_right
To err is human: Patient misinterpretations of prescription drug label instructions
Pat Bass
Patient Education and Counseling, 2007
View PDFchevron_right
Risk communication in clinical trials: A cognitive experiment and a survey
Cynthia Goh
BMC Medical Informatics and Decision Making, 2010
View PDFchevron_right
Thai Patients’ Drug Safety Knowledge and Perceptions Relating to Different Forms of Written Medicine Information: A Comparative Study
Juraporn Pongwecharak
Patient Preference and Adherence, 2022
View PDFchevron_right
Influence of Pharmacists??? Attitudes on Adverse Drug Reaction Reporting
Jorge Polonia
Drug Safety, 2006
View PDFchevron_right
Informing patients about serious side effects of drugs. A 2001 survey of 341 French rheumatologists
Pascale Guillot
Joint Bone Spine, 2003
View PDFchevron_right
Gist and verbatim communication concerning medication risks/benefits
Susan Blalock
Patient Education and Counseling, 2016
View PDFchevron_right
The Future of Risk Communication and the Role of the Pharmaceutical Industry
Sweta Chakraborty
View PDFchevron_right
Patient information leaflets: informing or frightening? A focus group study exploring patients' emotional reactions and subsequent behavior towards package leaflets of commonly prescribed medications in family practices
Petra Thürmann
BMC family practice, 2014
View PDFchevron_right
A Survey of patients' sources of knowledge of medication side effects and implications for compliances
Yaw Bimpeh, Vincent Agyapong
European Psychiatry, 2008
View PDFchevron_right
Risk Perception of Prescription Drugs
Barbara Fasolo
Medical Decision Making, 2013
View PDFchevron_right
Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies
Susan Blalock
Patient Preference and Adherence, 2015
View PDFchevron_right
What patients want to know about their medications
Sheri Burns
2002
View PDFchevron_right
Patient perspectives on how to improve education on medication side effects: cross-sectional observational study at a rheumatology clinic in The Netherlands
Mirjam Hegeman
Rheumatology International, 2021
View PDFchevron_right
Communication About Medications: Directions for Research
Bruce Lambert
Health Communication, 1994
View PDFchevron_right
The Challenge of Effectively Communicating Risk-Benefit Information
Bruce Hugman
Drug Safety, 1997
View PDFchevron_right